NEW YORK, NY, (NAMC) – The Danvers, Massachusetts based non- invasive blood pressure solutions manufacturer Medwave, Inc. (NASDAQ:MDWV) has completed a capital raising.

The company has raised over $4.43 million in additional capital for the company that will fund the growth and the product penetration of their Primo system and Legato OEM Developer's Kit brands.

According to the company the financing was led by H&Q Healthcare Investors (NYSE:HQH) and H&Q Life Sciences Investors (NYSE:HQL) . Hambrecht & Quist Capital Management LLC acted as the investment Advisor for H&Q Healthcare Investors and H&Q Life Sciences Investors.

Additional investors included Heartland Advisors of Milwaukee and additional assistance in the financing came from Nite Capital of Chicago, Paragon Capital of New York, and certain other smaller investors.

Medwave is trading at $3.05

J.C. Arens
Business News Correspondent
NAMC Newswire
www.namcnewswire.com

This article can be republished either online or in print as long as credit is given to the author and the NAMC Newswire.
 
NAMC Newswire articles can now be listened to on StreetIQ.com
http://www.streetiq.com/dir/NAMC.shtml#

To keep up to date with companies that we report on just register to receive the FREE Wall Street to Main Street Daily Newsletter. We feature companies that trade on the NYSE, AMEX, NASDAQ, OTCBB and Overseas, Keeping our readers informed daily. Just go to our site and register, it’s simple and free, www.namcnewswire.com/newsletter . Also be sure to visit the NAMC radio at www.namcnewswire.com/namcradio for the latest reports, interviews and corporate updates featured on the NAMC Newswire.